p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis
Fischer, Nicholas W, Prodeus, Aaron, Malkin, David, Gariépy, Jean
Published in Cell cycle (Georgetown, Tex.) (01.12.2016)
Published in Cell cycle (Georgetown, Tex.) (01.12.2016)
Get full text
Journal Article
Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
Prodeus, Aaron, Abdul-Wahid, Aws, Fischer, Nicholas W, Huang, Eric H-B, Cydzik, Marzena, Gariépy, Jean
Published in Molecular therapy. Nucleic acids (01.04.2015)
Published in Molecular therapy. Nucleic acids (01.04.2015)
Get full text
Journal Article
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
Prodeus, Aaron, Sparkes, Amanda, Fischer, Nicholas W., Cydzik, Marzena, Huang, Eric, Khatri, Ismat, Young, Ashley, Woo, Lindsay, Chow, Chung Wai, Gorczynski, Reginald, Gariépy, Jean
Published in Molecular therapy. Nucleic acids (07.09.2018)
Published in Molecular therapy. Nucleic acids (07.09.2018)
Get full text
Journal Article
Emerging insights into ethnic-specific TP53 germline variants
Fischer, Nicholas W, Ma, Yu-Heng Vivian, Gariépy, Jean
Published in JNCI : Journal of the National Cancer Institute (09.10.2023)
Published in JNCI : Journal of the National Cancer Institute (09.10.2023)
Get full text
Journal Article
Serum‐derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re‐modeling of the extracellular matrix that favors the engraftment of CEA‐expressing tumor cells
Abdul‐Wahid, Aws, Cydzik, Marzena, Fischer, Nicholas W., Prodeus, Aaron, Shively, John E, Martel, Anne, Alminawi, Samira, Ghorab, Zeina, Berinstein, Neil L., Gariépy, Jean
Published in International journal of cancer (15.10.2018)
Published in International journal of cancer (15.10.2018)
Get full text
Journal Article
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
Graziano, Francesco, Fischer, Nicholas W., Bagaloni, Irene, Di Bartolomeo, Maria, Lonardi, Sara, Vincenzi, Bruno, Perrone, Giuseppe, Fornaro, Lorenzo, Ongaro, Elena, Aprile, Giuseppe, Bisonni, Renato, Prisciandaro, Michele, Malkin, David, Gariépy, Jean, Fassan, Matteo, Loupakis, Fotios, Sarti, Donatella, Del Prete, Michela, Catalano, Vincenzo, Alessandroni, Paolo, Magnani, Mauro, Ruzzo, Annamaria
Published in Cancers (24.07.2020)
Published in Cancers (24.07.2020)
Get full text
Journal Article
VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses
Prodeus, Aaron, Abdul-Wahid, Aws, Sparkes, Amanda, Fischer, Nicholas W, Cydzik, Marzena, Chiang, Nicholas, Alwash, Mays, Ferzoco, Alessandra, Vacaresse, Nathalie, Julius, Michael, Gorczysnki, Reginald M, Gariépy, Jean
Published in JCI insight (21.09.2017)
Published in JCI insight (21.09.2017)
Get full text
Journal Article
Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network
Samuel, Nardin, Wilson, Gavin, Id Said, Badr, Pan, Anna, Deblois, Genevieve, Fischer, Nicholas W, Alexandrova, Roumiana, Casallo, Guillermo, Paton, Tara, Lupien, Mathieu, Gariepy, Jean, Merico, Daniele, Hudson, Thomas J, Malkin, David
Published in Oncotarget (02.08.2016)
Published in Oncotarget (02.08.2016)
Get full text
Journal Article
Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy
Ruzzo, Annamaria, Graziano, Francesco, Palladino, Silvia, Fischer, Nicholas W, Catalano, Vincenzo, Giordani, Paolo, Malkin, David, Tamburrano, Tiziana, Patriti, Alberto, Petrelli, Filippo, Sarti, Donatella, Chiari, Rita
Published in The oncologist (Dayton, Ohio) (22.10.2024)
Published in The oncologist (Dayton, Ohio) (22.10.2024)
Get full text
Journal Article
Abstract A005 TP53 variant clusters stratify the Li-Fraumeni spectrum and reveal an osteosarcoma-prone subgroup
Fischer, Nicholas W., Laverty, Brianne, Alon, Noa, Montellier, Emilie, Hainaut, Pierre, Maxwell, Kara N., Kratz, Christian P., Malkin, David
Published in Cancer research (Chicago, Ill.) (05.09.2024)
Published in Cancer research (Chicago, Ill.) (05.09.2024)
Get full text
Journal Article
S erum‐derived carcinoembryonic antigen ( CEA ) activates fibroblasts to induce a local re‐modeling of the extracellular matrix that favors the engraftment of CEA ‐expressing tumor cells
Abdul‐Wahid, Aws, Cydzik, Marzena, Fischer, Nicholas W., Prodeus, Aaron, Shively, John E, Martel, Anne, Alminawi, Samira, Ghorab, Zeina, Berinstein, Neil L., Gariépy, Jean
Published in International journal of cancer (15.10.2018)
Published in International journal of cancer (15.10.2018)
Get full text
Journal Article
Abstract 844: Germline TP53 missense mutations at codon338 confer adult-onset cancer risk through weakened p53 protein oligomeric stability that impairs its tumor suppressive mechanisms
Fischer, Nicholas W., Turk, Jaime, Ong, Noel, Duan, Shili, Kaustov, Lilia, Kratz, Christian, Pajtler, Kristian, Kim, Raymond, Arrowsmith, Cheryl, Malkin, David
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract NG05: TP53-mediated human cancer susceptibility is defined by epigenetic dysregulation of microRNA-34A
Samuel, Nardin, Wilson, Gavin, Deblois, Genevieve, Said, Badr Id, Fischer, Nicholas W., Lemire, Mathieu, Lou, Youliang, Li, Weili, Alexandrova, Roumiana, Novokmet, Ana, Tran, James, Nichols, Kim E., Finlay, Jonathan L., Choufani, Sanaa, Remke, Marc, Ramaswamy, Vijay, Cavalli, Florence M.G., Elser, Christine, Meister, Lynn, Taylor, Michael D., Tabori, Uri, Irwin, Meredith, Weksberg, Rosanna, Wasserman, Jonathan D., Gariepy, Jean, Lupien, Mathieu, Merico, Daniele, Paterson, Andrew, Hansford, Jordan R., Achatz, Maria Isabel W., Hudson, Thomas J., Malkin, David
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article